Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Year Year arrow
arrow-active-down-0
Publisher Publisher arrow
arrow-active-down-1
Journal
1
Journal arrow
arrow-active-down-2
Institution Institution arrow
arrow-active-down-3
Institution Country Institution Country arrow
arrow-active-down-4
Publication Type Publication Type arrow
arrow-active-down-5
Field Of Study Field Of Study arrow
arrow-active-down-6
Topics Topics arrow
arrow-active-down-7
Open Access Open Access arrow
arrow-active-down-8
Language Language arrow
arrow-active-down-9
Filter Icon Filter 1
Export
Sort by: Relevance
  • New
  • Research Article
  • 10.1016/j.phrs.2026.108120
Multiple protease-activated probody-drug conjugates for treating CD147-positive ovarian cancer with limited toxicity.
  • Mar 1, 2026
  • Pharmacological research
  • Bo Wang + 9 more

  • New
  • Research Article
  • 10.1016/j.phrs.2026.108128
Targeting the SARM1-NAD⁺ axis: A review of new strategy for reversing the imbalance of energy and mitochondrial homeostasis in metabolic diseases.
  • Mar 1, 2026
  • Pharmacological research
  • Ao Xiong + 4 more

  • New
  • Research Article
  • 10.1016/j.phrs.2026.108114
The SAM-m6A axis as an unexplored therapeutic hub for plant-derived regulation of disease metabolism.
  • Mar 1, 2026
  • Pharmacological research
  • Yuxuan Zhao + 4 more

  • New
  • Research Article
  • 10.1016/j.phrs.2026.108132
Pathophysiological significance of the TRPM2 ion channel as a potential target in cancer, neurological disorders, and ischemia/reperfusion injury.
  • Mar 1, 2026
  • Pharmacological research
  • Sara Sultana + 3 more

  • New
  • Research Article
  • 10.1016/j.phrs.2026.108127
Histone H4 lysine 5 lactylation: A key regulator of immune metabolism in microglia during ischemic stroke.
  • Mar 1, 2026
  • Pharmacological research
  • Yishan Li + 6 more

  • New
  • Research Article
  • 10.1016/j.phrs.2026.108137
Inhibition of Kdm2a with Daminozide suppresses high myopia progression and related neuropsychiatric comorbidities by epigenetically modulating the gut-eye axis.
  • Mar 1, 2026
  • Pharmacological research
  • Zixuan Li + 18 more

  • New
  • Research Article
  • 10.1016/j.phrs.2026.108143
Manipulating metabolism-reprogrammed monocytic-MDSCs prevents colitis-associated dysplasia by IL-10/HIF-1α/DLL4 signaling.
  • Mar 1, 2026
  • Pharmacological research
  • Yirui Wang + 14 more

  • New
  • Research Article
  • 10.1016/j.phrs.2026.108135
Gut-liver axis dysregulation in colitis underlies structure-dependent pharmacokinetics of a traditional Chinese medicine.
  • Mar 1, 2026
  • Pharmacological research
  • Ka Wing Cheng + 19 more

  • New
  • Research Article
  • 10.1016/j.phrs.2026.108122
Targeting FoxO1 in cardiovascular diseases: Mechanisms and therapeutic potential.
  • Mar 1, 2026
  • Pharmacological research
  • Xue Wu + 2 more

  • New
  • Research Article
  • 10.1016/j.phrs.2026.108136
Cytokine epigenetics network for gastric cancer progression and chemoresistance.
  • Mar 1, 2026
  • Pharmacological research
  • Ganji Purnachandra Nagaraju + 4 more